A pharmaceutical company needs to grant temporary Read and Edit access to the custom Clinical Trial object for five quality assurance specialists. These five specialists are assigned to different baseline profiles across various departments. Once the three-month clinical trial audit concludes, their elevated access must automatically cease without altering the access rights of other users who share their base profiles. Which TWO configuration steps should the administrator implement to meet these requirements efficiently? (Select 2)
- Create a permission set that grants Read and Edit access to the Clinical Trial object and assign it to the five quality assurance specialists.Answer
- BClone the baseline profiles for each department, enable Read and Edit permissions on the Clinical Trial object, and reassign the five specialists to the new profiles.
- Specify an expiration date on the permission set assignment for each of the five specialists corresponding to the end of the audit.Answer
- DUpdate the Organization-Wide Defaults for the Clinical Trial object to Public Read/Write for the duration of the audit period.
Answer
The administrator should create a permission set granting Read and Edit permissions on the Clinical Trial object for the specialists, and set an expiration date on those permission set assignments to ensure access automatically ends after the three-month audit.
Permission sets provide additive permissions to specific users without altering base profiles shared by other users. Combining a permission set with assignment expiration dates handles temporary access requirements cleanly by automatically removing elevated permissions when the specified date is reached.
Step-by-Step Solution
Key Concept
Permission Sets and Permission Set Assignment Expiration